Mcm-2 protein expression predicts prognosis better than Ki-67 antigen in oral cavity squamocellular carcinoma

Anticancer Research

Volumn 26, Issue 3 B, 2006, Pages 2473-2478

  Szelachowska, Jolanta ^a   Dziegiel, Piotr ^a   Jelen Krzeszewska, Joanna ^a   Jelen, Michal ^a   Matkowski, Rafal ^a   Pomiecko, Agnieszka ^b   Spytkowska, Barbara ^b   Jagas, Maria ^b   Gisterek, Iwona ^a   Kornafel, Jan ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b 4th Department of Internal Medicine and Pulmonology   (Poland)

Author keywords

Ki 67; Mcm 2; Oral cancer; Prognosis; Squamocellular carcinoma

Indexed keywords

KI 67 ANTIGEN; MINICHROMOSOME MAINTENANCE PROTEIN 2;

ADULT; ARTICLE; CANCER CELL; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUTH CARCINOMA; MOUTH CAVITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TONGUE CANCER;

CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 33745535972     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Bryne M, Boysen M and Alfsen CG: The invasive front of carcinomas. The most important area for tumour prognosis? Anticancer Res 18: 4757-4764, 1998.
2. Piffko J, Bankfalvi A, Ofner D, Kusch F, Bokker W and Joos U: In situ assessment of cell proliferation at the invasive front of oral squamous cell carcinomas. Virchows Arch 429: 229-234, 1996.
3. Prelich G, Tan CK, Kostura M, Mathews MB, So AG, Downey KM and Stillman B: Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature 326: 517-520, 1987.
4. Toshi L and Bravo R: Changes in cyclin/proliferating cell nuclear antigen distribution during DNA repair synthesis. J Cell Biol 107: 1623-1628, 1988.
5. MacCallum DE and Hall PA: The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle. J Pathol 190: 537-544, 2000.
6. Scholzen T and Gerdes J: The Ki-67 protein: from the known and the unknown. J Cell Physiol 182: 311-322, 2000.
7. van Oijen MG, Medema RH, Slootweg PJ and Rijksen G: Positivity of the proliferation marker Ki-67 in noncycling cells. Am J Clin Pathol 110: 24-31, 1998.
8. Baisch H and Gerdes J: Simultaneous staining of exponentially growing versus plateau phase cells with the proliferation-associated antibody Ki-67 and propidium iodide: analysis by flow cytometry. Cell Tissue Kinet 20: 387-391, 1987.
9. Daidone MG and Silvestrini R: Prognostic and predictive role of proliferation indices in adjuvant therapy of breast cancer. J Natl Cancer Monogr 27-35, 2001.
10. Dziegiel P, Forgacz J, Suder E, Surowiek P, Kornafel J and Zabel M: Prognostic significance of metallothionein expression in correlation with Ki-67 expression in adenocarcinomas of large intestine. Histol Histopathol 18: 401-407, 2003.
11. Dziegiel P, Salwa-Zurawska W, Zurawski J, Wojnar A and Zabel M: Prognostic significance of augmented metallothionein expression correlated with Ki-67 antigen expression in selected soft tissue sarcomas. Histol Histopathol 20: 83-89, 2005.
12. Krecicki T, Jelen M, Zalesska-Krecicka M and Szkudlarek-Gruszczynska T: Ki-67 immunostaining and prognosis in laryngeal cancer. Clin Otolaryngol 23: 539-542, 1998.
13. Krecicki T, Jelen M, Zalesska-Krecicka M, Rak J, Szkudlarek-Gruszczynska T and Jelen-Krzeszewska J: Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions. Oral Oncol 35: 180-186, 1999.
14. Ofner D, Grothaus A and Riedmann B: MIB-1 in colorectal carcinomas: its evaluation by three different methods reveals lack of prognostic significance. An Cell Path 12: 61-70, 1996.
15. Tungekar MF, Gatter KC, Dunnill MS and Mason DY: Ki-67 immunostaining and survival in operable lung cancer. Histopathology 19: 545-550, 1991.
16. Bettendorf O and Herremann G: Prognostic relevance of Ki-67 antigen expression in 329 cases of oral squamous cell carcinoma. ORL 64: 200-205, 2002.
17. Verheijen R, Kuijpers HJ, Schlingemann RO, Boehmer AL, van Driel R, Brakenhoff GJ and Ramaekers FC: Ki-67 detects a nuclear matrix-associated proliferation-related antigen. Intracellular localization during interphase. J Cell Sci 92: 123-130, 1989.
18. Tye BK: Mcm proteins in DNA replication. Annu Rev Biochem 68: 649-686, 1999.
19. Thommes P, Fett R, Schray B, Burkhart R, Barnes M, Kennedy C, Brown NC and Knippers R: Properties of the nuclear P1 protein, a mammalian homologue of the yeast Mcm3 replication protein. Nucleic Acids Res 20: 1069-1074, 1992.
20. Kearsey SE and Labib K: MCM proteins: evolution, properties and role in DNA replication. Biochim Biophys Acta 1398: 113-136, 1998.
21. Ritzi M and Knippers R: Initiation of genome replication: assembly and disassembly of replication-competent chromatin. Gene 245: 13-20, 2000.
22. Tanaka T, Knapp D and Nasmyth K: Loading of an Mem protein onto DNA replication origins is regulated by Cdc6p and CWKs. Cell 90: 649-660, 1997.
23. Laskey RA and Madine MA: A rotary pumping model for helicase function of Mem proteins at a distance from replication forks. EMBO Rep 4: 26-30, 2003.
24. Romanowski P and Madine MA: Mechanisms restricting DNA replication to once per cell cycle: the role of Cdc 6 and ORC. Trends Cell Biol 7: 9-10, 1997.
25. Stoeber K, Mills AD, Kubota Y, Krude T, Romanowski P, Marheineke K, Laskey RA and Williams GH: Cdc6 protein causes premature entry into S-phase in a mammalian cell-free system. EMBO J 17: 7219-7229, 1998.
26. Williams RS, Shohet RV and Stilman B: A human protein related to yeast Cdc6p. Proc Natl Acad Sci USA 94: 142-147, 1997.
27. Yan Z, DeGregori J, Shohet R, Leone G, Stillman B, Nevins JR and Williams RS: Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc Natl Acad Sci USA 95: 3603-3608, 1998.
28. Stoeber K, Tlsty TD, Happerfield L, Thomas GA, Romanov S, Bobrow I, Williams ED and Williams GH: DNA replication licensing and human cell proliferation. J Cell Sci 114: 2027-2041, 2001.
29. Gonzalez MA, Pinder SE, Callagy G, Vowler SL, Morris LS, Bird K, Bell JA, Laskey RA and Coleman N: Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer. J Clin Oncol 21: 4306-4313, 2003.
30. Rodins K, Cheale M, Coleman N and Fox SB: Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility. Clin Cancer Res 8: 1075-1081, 2002.
31. Meng MV, Grossfeld GD, Williams GH, Dilworth GD, Stoeber K, Mulley TW, Weinberg V, Carroll PR and Tlsty TD: Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer. Clin Cancer Res 7: 2712-2718, 2001.
32. Ramnath N, Hernandez FJ, Tan DF, Huberman JA, Natarajan N, Beck AF, Hyland A, Todorov IT, Brooks JSJ and Bepler G: Mcm2 is an independent predictor of survival in patients with non-small-cell lung cancer. J Clin Oncol 19: 4259-4266, 2001.
33. Kato H, Miyazaki T, Fukai Y, Nakajima M, Sohda M, Takita J, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Asao T and Kuwano H: A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma. J Surg Oncol 84: 24-30, 2003.
34. Chatrath P, Scott IS, Morris LS, Davies RJ, Rushbrook SM, Bird K, Vowler SL, Grant JW, Saeed IT, Howard D, Laskey RA and Coleman N: Aberrant expression of minichromosome maintenance protein-2 and Ki-67 in laryngeal squamous epithelial lesions. Br J Cancer 15: 1048-1054, 2003.
35. Wharton SB, Chan KK, Anderson JR, Stoeber K and Williams GH: Replicative Mcm2 protein as a novel proliferation marker in oligodendrogliomas and its relationship to Ki-67 labelling index, histological grade and prognosis. Neuropathol Appl Neurobiol 27: 305-313, 2001.